Antimicrobial Drug Resistance

Clinical and Epidemiological Aspects, Volume 2

  • Douglas L. Mayers
  • Jack D. Sobel
  • Marc Ouellette
  • Keith S. Kaye
  • Dror Marchaim

Table of contents

  1. Front Matter
    Pages i-xxi
  2. Gram Positive Bacterial Drug Resistance: Clinical

    1. Front Matter
      Pages 775-775
    2. Lesley McGee, Keith P. Klugman
      Pages 777-790
    3. Nainee Desai, Judith Steenbergen, David E. Katz
      Pages 791-810
    4. Katherine Reyes, Marcus Zervos, Jisha John
      Pages 811-818
    5. David J. Weber, Melissa B. Miller, William A. Rutala
      Pages 827-840
  3. Gram Negative Bacterial Drug Resistance: Clinical

    1. Front Matter
      Pages 841-841
    2. Margaret C. Bash, Kathryn A. Matthias
      Pages 843-865
    3. David L. Paterson, Yohei Doi
      Pages 889-898
    4. Kamilia Abdelraouf, Vincent H. Tam
      Pages 899-922
    5. Federico Perez, Robert A. Bonomo
      Pages 923-935
    6. Michael L. Bennish, Wasif A Khan, Sabeena Ahmed
      Pages 969-990
    7. Patrick F. McDermott, Francis Mégraud
      Pages 991-1006
    8. Itzhak Brook
      Pages 1007-1040
    9. Akos Somoskovi, Max Salfinger
      Pages 1041-1059
    10. Kathleen L. Horan, Gerard A. Cangelosi
      Pages 1061-1071
  4. Fungal Drug Resistance: Clinical

    1. Front Matter
      Pages 1073-1073
    2. P. H. Chandrasekar, Elias K. Manavathu
      Pages 1099-1118
    3. Kimberly E. Hanson, Jelena Catania, Barbara D. Alexander, John R. Perfect
      Pages 1119-1140
    4. Jannik Helweg-Larsen, Thomas Benfield, Joseph Kovacs, Henry Masur
      Pages 1147-1162
  5. Viral Drug Resistance: Clinical

    1. Front Matter
      Pages 1163-1163
    2. Erhard van der Vries, Michael G. Ison
      Pages 1165-1183
    3. Jocelyne Piret, Guy Boivin
      Pages 1185-1211
    4. Douglas L. Mayers, John D. Baxter
      Pages 1213-1225
    5. Apostolos Beloukas, Anna Maria Geretti
      Pages 1227-1242
  6. Parasitic Drug Resistance: Clinical

    1. Front Matter
      Pages 1243-1243
    2. Jeffrey D. Smith, Sarah L. Cudmore, Gary E. Garber
      Pages 1277-1291
    3. Shyam Sundar, Jaya Chakravarty
      Pages 1293-1304
  7. Measurements of Drug Resistance

    1. Front Matter
      Pages 1327-1327
    2. Robert W. Buckheit Jr., R. Dwayne Lunsford
      Pages 1329-1345
    3. Sebastian G. Kurz, Max Salfinger
      Pages 1359-1365
    4. Sevtap Arikan-Akdagli, John H. Rex
      Pages 1367-1387
    5. Jacqueline D. Reeves, Neil T. Parkin
      Pages 1389-1407
    6. Danielle Légaré, Marc Ouellette
      Pages 1409-1463
    7. A. Huletsky, Michel G. Bergeron
      Pages 1465-1499
  8. Public Health Issues of Drug Resistance

    1. Front Matter
      Pages 1517-1517
    2. Joseph D. Lutgring, Carlos A. Diaz Granados, John E. McGowan Jr.
      Pages 1519-1528
    3. Tara N. Palmore, David K. Henderson
      Pages 1551-1564
    4. Linda M. Weigel, Stephen A. Morse
      Pages 1565-1591

About this book


The two volumes included in Antimicrobial Drug Resistance, Second Edition is an updated, comprehensive and multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. This newly revised compendium reviews the most current research and development on drug resistance while still providing the information in the accessible format of the first edition. The first volume, Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant organisms, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of those currently available. The second volume, Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious diseases physician requires input from the clinical microbiologist, antimicrobial stewardship personnel, and infection control specialist to make informed choices for the effective management of various strains of drug-resistant pathogens in individual patients. This 2-volume set is an important reference for students in microbiology, infectious diseases physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners.


assays epidemiology public health antibiotics antivirals infectious disease pathogens antifungal drug resistance

Editors and affiliations

  • Douglas L. Mayers
    • 1
  • Jack D. Sobel
    • 2
  • Marc Ouellette
    • 3
  • Keith S. Kaye
    • 4
  • Dror Marchaim
    • 5
  1. 1.Treiber TherapeuticsCambridgeUSA
  2. 2.Wayne State University School of Medicine, Detroit Medical CenterDetroitUSA
  3. 3.Canada Research Chair in Antimicrobial Resistance, Centre de recherche en InfectiologieUniversity of LavalQuebec CityCanada
  4. 4.Division of Infectious DiseasesUniversity of Michigan Medical SchoolAnn ArborUSA
  5. 5.Infection Control and Prevention Unit of Infectious Diseases, Assaf Harofeh Medical Center, Sackler Faculty of MedicineTel-Aviv UniversityTel AvivIsrael

Bibliographic information